Patents by Inventor Jeehee Youn

Jeehee Youn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for preventing or treating Th17-mediated disease comprising poly-gamma-glutamic acid
    Patent number: 9144593
    Abstract: Provided are a pharmaceutical use of poly-gamma-glutamic acid used for preventing or treating Th17-mediated diseases, a composition for preventing or treating Th17-mediated diseases comprising poly-gamma-glutamic acid as an active ingredient, and a method of preventing or treating Th17-mediated diseases using the same. The pharmaceutical composition is effective in inhibiting the differentiation of Th17 cells while promoting Treg cells, and, thus, can be useful in preventing or treating Th17-mediated diseases such as multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, Crohn's disease, ankylosing spondylitis, and the like.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: September 29, 2015
    Assignee: Industry-University Cooperation Foundation Hanyang University
    Inventors: Jeehee Youn, Kyuheon Lee, Sejin Hwang
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TH17-MEDIATED DISEASE COMPRISING POLY-GAMMA-GLUTAMIC ACID
    Publication number: 20130267463
    Abstract: Provided are a pharmaceutical use of poly-gamma-glutamic acid used for preventing or treating Th17-mediated diseases, a composition for preventing or treating Th17-mediated diseases comprising poly-gamma-glutamic acid as an active ingredient, and a method of preventing or treating Th17-mediated diseases using the same. The pharmaceutical composition is effective in inhibiting the differentiation of Th17 cells while promoting Treg cells, and, thus, can be useful in preventing or treating Th17-mediated diseases such as multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, Crohn's disease, ankylosing spondylitis, and the like.
    Type: Application
    Filed: November 15, 2012
    Publication date: October 10, 2013
    Applicant: Industry-University Cooperation Foundation Hanyang University
    Inventors: Jeehee YOUN, Tae-Hwan KIM, Kyuheon LEE
  • Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
    Publication number: 20040082664
    Abstract: The present invention relates to derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition, more particularly the compounds of the present invention specifically inhibit the activation of T lymphocyte by src homology region 2(SH2) domain of T lymphocyte (lck), so that they can be used for the treatment, prevention and/or diagnosis of graft rejection, autoimmune diseases, inflammatory diseases, etc.
    Type: Application
    Filed: April 11, 2003
    Publication date: April 29, 2004
    Inventors: Jongwha Won, Keunhyeung Lee, Seehyoung Park, Sung-Joo Kim, Su-Young Yun, Mi-Ae Kang, Yun-Gyoung Hur, Jeehee Youn, Yungdae Yun, Doohong Park, Jaetaek Oh